	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	155.82	131.57	77.67	18.4%	100.6%
Operating Profit Qtr	17.75	14.73	9.42	20.5%	88.4%
Net Profit Qtr	17.69	13.00	7.40	36.1%	139.1%
Earning Per Share Adjusted latest Qtr	0.19	0.14	0.08	35.7%	137.5%

* Consolidated data

Detailed Results

Syncom Formulation (India) Ltd.

19 May 2025

20.76

-1.98%

Board Meeting

Syncom Formulations India Ltd-$ - 524470 - Board Meeting Outcome for Regulation 33(3)(D) Of SEBI (LODR) …

BSE India

Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors' Report thereon by Statutory Auditors, Statement of Assets and Liabilities and Cash Flow for the quarter/year ended on 31st March, 2025, in PDF Format, which were approved by the Audit Committee and Board of Directors at their meeting held on Monday, 19th May, 2025.

pdf

Syncom Formulation (India) Ltd.

13 May 2025

20.76

-1.98%

Board Meeting

Syncom Formulations India Ltd-$ - 524470 - Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of …

BSE India

Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve a) To consider and approve Standalone and Consolidated Audited Financial Results of the Company for the Quarter and year ended 31st March, 2025; b) To take on record the Standalone and Consolidated Audit Report by Auditors for the Audited Financial Results of the Company for the Quarter and year ended 31st March, 2025. c) To consider and approve other matter incidental thereto

pdf

Syncom Formulation (India) Ltd.

13 May 2025

20.76

-1.98%

Corp. Note

Syncom Formulations India Ltd-$ - 524470 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySyncom Formulations India Ltd- 2CIN NO.L24239MH1988PLC047759 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: VAISHALI AGRAWAL Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: finance@sfil.in Name of the Chief Financial Officer: Ankit Kedarmal Bankda Designation: CFO EmailId: ankit@sfil.in Date: 13/05/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Syncom Formulation (India) Ltd.

17 Apr 2025

20.76

-1.98%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate for Compliance of Regulation 74(5) of SEBI, DP REG 2018 for the Quarter ended 31.03.2025

pdf

Syncom Formulation (India) Ltd.

05 Apr 2025

20.76

-1.98%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Announcement Under Regulation 30

BSE India

Announcement under Regulation 30 for the demand raised under section 74 (5) of CGST ACT, 2017

pdf

Syncom Formulation (India) Ltd.

25 Mar 2025

20.76

-1.98%

SAST

Syncom Formulations India Ltd-$ - 524470 - Closure of Trading Window

BSE India

We would inform you that pursuant to SEBI (PIT) Reg, 2015 as amended from time to time, the trading window shall remain close from 1st April, 2025 till completion of 48 hours after the declaration of Audited Standalone and Consolidated Financial result for the quarter and year ended on 31st March, 2025.

pdf